Involves transaction of at least 0.5% of the listed shares of a company. What was Sanofi India Ltd share price previously? Sanofi India Ltd share price was up by 3.49% from the previous closing ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Sanofi has agreed to purchase its own shares worth €2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.

Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.

The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 ...

Valeo Financial Advisors LLC decreased its holdings in Sanofi (NASDAQ:SNY – Free Report) by 62.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund ...

Sanofi Consumer Healthcare India Ltd share price was down by 0.00% from the previous closing price of ₹4,706.90. Who are peers of Sanofi Consumer Healthcare India Ltd? The peers of Sanofi ...

Deal to boost Sanofi's earnings per share and shareholder value ... reflecting a discount of 2.8% to the closing price on January 31, 2025. The total transaction amounts to 3 billion euros ...

Sanofi announces buy back of shares from L’Oréal Paris, 3, 2025. Sanofi today announces the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi ...

Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...

Sanofi said the acquisition would be of 2.3% of its shares from L'Oréal. This transaction is part of a share buyback programme announced on January 30, which will involve the acquisition of 29,556,650 ...